Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava (Fumariaceae)

Natural Product Communications

Volumn 6, Issue 5, 2011, Pages 607-610

  Chlebek, Jakub ^a   Macáková, Kateřina ^a   Cahlíková, Lucie ^a   Kurfürst, Milan ^b   Kuneš, Jiří ^a   Opletal, Lubomír ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b INSTITUTE OF CHEMICAL PROCESS FUNDAMENTALS   (Czech Republic)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Corydalis cava; Fumariaceae; Red blood cells

Indexed keywords

ACETYLCHOLINESTERASE; ALKALOID DERIVATIVE; ALLOCRYPTOPINE; BULBOCAPNINE; CANADALINE; CANADINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CORYCAVAMINE; CORYCAVIDINE; CORYDALINE; CORYDALIS CAVA EXTRACT; CORYDINE; CORYNOLIN; CORYPALMINE; GALANTAMINE; HUPERZINE A; ISOCORYPALMINE; N METHYLLAUROTETANINE; PLANT EXTRACT; SCOULERINE; SINOACUTINE; TETRAHYDROPALMATINE; UNCLASSIFIED DRUG;

ARTICLE; CHOLINESTERASE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORYDALIS; CORYDALIS CAVA; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; NONHUMAN;

CORYDALIS CAVA; FUMARIACEAE;

EID: 79955862259     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1100600507     Document Type: Article

References (35)

1. (a) Park SY. (2010) Potential therapeutic agents against Alzheimer's disease from natural sources. Archives of Pharmacal Research, 33, 1589-1609;
2. (b) Mattson MP, Maudsley S, Martin BA. (2004) A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Research Reviews, 3, 445-464;
3. (c) Iqbal K, Liu F, Gong CX, Alonso AC, Grundke-Iqbal I. (2009) Mechanism of tau-induced neurodegeneration. Acta Neuropathologica, 118, 53-69;
4. (d) Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237-1239;
5. (e) Lahiri DK, Farlow MR, Greig NH, Sambamurti K. (2002) Current drug targets for Alzheimer's disease treatment. Drug Development Research, 56, 267-281;
6. (f) Greig NH, Lahiri DK, Sambamurti K. (2002) Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. International Psychogeriatrics, 14, 77-91;
7. (g) Maelicke A, Samochocki M, Jostok R, A, Ludwig J, Albuquerque EX, Zerlin M. (2001) Allosteric sensitization of nicotinic receptors by galanthamine, a new treatment strategy for the Alzheimer's disease. Biological Psychiatry, 26, 279-288;
8. (h) Lleó A. (2007) Current therapeutic options for Alzheimer's disease. Current Genomics, 8, 550-558;
9. (i) Recanatini M, Valenti P. (2004) Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics. Current Pharmaceutical Design, 10, 3157-3166. (Pubitemid 39242910)
10. (a) Berkov S, Bastida J, Nikolova M, Viladomat F, Codina C. (2008) Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts. Phytochemical Analysis, 19, 411-419;
11. (b) Hostettmann K, Borloz A, Urbain A, Marston A. (2006) Natural product inhibitors of acetylcholinesterase. Current Organic Chemistry, 10, 825-847;
12. (c) Mukherjee PK, Kumar V, Mal M, Houghton PJ. (2007) Acetylcholinesterase inhibitors from plants. Phytomedicine, 14, 289-300. (Pubitemid 46415622)
13. (a) Houghton PJ, Ren Y, Howes MJ. (2006) Acetylcholinesterase inhibitors from plants and fungi. Natural Products Reports, 23, 181-199;
14. (b) Preininger V, Thakur RS, Šantavý F. (1976) Isolation and chemistry of alkaloids from plants of the family Papaveraceae LXVII: Corydalis cava (L.) Sch. et K. (C. tuberosa DC). Journal of Pharmaceutical Sciences, 65, 294-296;
15. (c) Slavík J, Slavíková L. (1979) Alkaloids from Corydalis cava (L.) Schw. et Koerte. Collection of Czechoslovak Chemical Communications, 44, 2261-2274;
16. (d) Preininger V. (1986). In:The Alkaloids , Brossi A (Ed.) Vol. 29, Academic Press, New York, 1-98;
17. (e) Meyer A, Imming P. (2008) R(-)-Canadaline as first secoberbine alkaloid from Corydalis cava. Phytochemistry Letters, 1, 168-170;
18. (f) Adsersen A, Kjølbye A, Dall O, Jäger AK. (2007) Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. Journal of Ethnopharmacology, 113, 179-182;
19. (g) Hung TM, Na MK, Dat NT, Ngoc TM, Youn U, Kim HJ, Min BS, Lee JP, Bae KH. (2008) Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii. Journal of Ethnopharmacology, 119, 74-80;
20. (h) Whiteley CG, Daya S. (1995) Protein ligand interactions. Part 5: Isoquinoline alkaloids as inhibitors of acetylcholinesterase from Electrophorus electricus. Journal of Enzyme Inhibition, 9, 285-294;
21. (i) Khorana N, Markmee S, Ingkaninan K, Ruchirawat S, Kitbunnadaj R, Pullagurla MR. (2009) Evaluation of new lead for acetylcholinesterase inhibition. Medicinal Chemistry Research, 18, 231-241.
22. (a) Halbsguth CH, Miessner O, Häberlein H. (2003) Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABAA binding site. Planta Medica, 69, 305-309;
23. (b) Gleye J, Ahon A, Edouard S. (1974) Canadaline. New alkaloid from Hydrastis canadensis. Phytochemistry, 13, 675-676;
24. (c) Shamma M, Salgar SS. (1973) Pallidine and corydine from Thalictrum dioicum. Phytochemistry, 12, 1505-1506;
25. (d) de Wet H, van Herden FR, van Wyk BE. (2005) Alkaloids of Antizoma miersiana (Menispemaceae). Biochemical Systematics and Ecology, 33, 799-807;
26. (e) Slavík J, Slavíková L. (1989) Alkaloids from Corydalis nobilis (L.) Pers. and C. intermedia (L.) Mérat. Collection of Czechoslovak Chemical Communications, 54, 2009-2019.
27. (a) Galeffi C, Cometa MF, Tomassini L, Nicoletti M. (1997) Canadinic acid: an alkaloid from Hydrastis canadensis. Planta Medica, 63, 194;
28. (b) Wu Y-R, Zhao Y-X, Liu Y-Q, Zhou J. (2007) Isoquinoline alkaloids from Corydalis taliensis. Zeitschrift für Naturforschung B: Biochemical Sciences, 62, 1199-1202;
29. (c) Kim DK. (2002) Inhibitory effect of corynoline isolated from the aerial parts of Corydalis incisa on the acetylcholinesterase. Archives of Pharmacal Research, 25, 817-819;
30. (d) Ma W, Fukushi Y, Tahara S. (1999) Fungitoxic alkaloids from Hokkaido Corydalis species. Fitoterapia, 70, 258-265;
31. (e) Denisenko ON, Israilov IA, Yunusov MS. (1991) Alkaloids from Corydalis caucasica. Khimiya Priridnykh Soedinenii, 3, 439-440;
32. (f) Zeng W, Liang W, Tu G. (1987) Chemical study of alkaloids from Corydalis bungeana. Planta Medica, 53, 418-420.
33. Cahlíková L, Macáková K, Kuneš J, Kurfürst M, Opletal L, Cvačka J, Chlebek J, Blunden G. (2010) Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Eschscholzia californica (Papaveraceae). Natural Product Communications, 5, 1035-1038.
34. Ellman GL, Courtney KD, Andres V, Featherstone RM. (1961) A new rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88-95.
35. Steck TL, Kant JA. (1974) Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods in Enzymology, 31 (Pt A), 172-180.